Suppr超能文献

P2X7 受体+1513(A-->C)多态性与旁遮普人群结核病的关联。

Association of P2X7 receptor +1513 (A-->C) polymorphism with tuberculosis in a Punjabi population.

机构信息

Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, Punjab, India.

出版信息

Int J Tuberc Lung Dis. 2010 Sep;14(9):1159-63.

Abstract

BACKGROUND

Development of tuberculosis (TB) disease is an outcome of complex host-pathogen interactions. The purinergic P2X(7) receptors are adenosine triphosphate gated molecules shown to induce killing of intracellular Mycobacterium tuberculosis, followed by apoptosis of the infected macrophage. A single nucleotide polymorphism in exon 13 of the P2X(7) receptors gene at +1513 position has been shown to abolish the function of this receptor and to be associated with increased susceptibility to TB in some ethnic groups.

OBJECTIVE

To explore the association of +1513 (A-->C) polymorphism in TB patients in Punjab, North India.

DESIGN

A case-control study was conducted by studying peripheral blood samples from 204 TB patients (181 pulmonary, 23 extra-pulmonary) and 177 controls with no history of TB. P2X(7) +1513 (A-->C) polymorphism was studied using amplification refractory mutation system analysis.

RESULT

The distribution of +1513 A/C genotypes in the TB patient and the control groups revealed a statistically significant association with TB (P = 0.002).

CONCLUSION

The +1513C allele is a risk factor for the development of TB in the North Indian Punjabi population.

摘要

背景

结核病(TB)的发展是宿主-病原体相互作用的复杂结果。嘌呤能 P2X(7)受体是三磷酸腺苷门控分子,已被证明可诱导细胞内结核分枝杆菌的杀伤,随后感染的巨噬细胞发生凋亡。已发现 P2X(7)受体基因第 13 外显子在 +1513 位的单核苷酸多态性可使该受体丧失功能,并与某些族群中结核病的易感性增加有关。

目的

探讨印度旁遮普邦结核病患者中+1513(A-->C)多态性的相关性。

设计

通过研究 204 例结核病患者(181 例肺部,23 例肺外)和 177 例无结核病史的对照者的外周血样本进行病例对照研究。采用扩增受阻突变系统分析研究 P2X(7)+1513(A-->C)多态性。

结果

TB 患者和对照组中+1513A/C 基因型的分布与 TB 存在统计学显著关联(P=0.002)。

结论

+1513C 等位基因是印度旁遮普邦人群发生结核病的危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验